About NovaXS
NovaXS is a smart medical device startup on a mission to simplify the medication administration process and improve treatment outcome with our patent-pending smart needle-free drug delivery platform, Telosis.
Our vision
To build a needle-free, transformative, and interactive drug delivery platform and present to the market a world-leading and life-changing biological proteins that treat chronic diseases.
Patricia
Geli
(Board Advisor)
Executive Director and Global Secretariat of Reform for Resilience Commission
Haley E.
Titus, PhD
(VP of Clinical Operations)
NU FSM Neuroimmunologist,
15+ years in Translational Medicine
Shuhua
Zhang
(Software Director)
Entrepreneur, 5+ years in SDE, AWS Certified Solution Architect
Eric
Pulver
(Scientific Advisor)
Healthcare innovator/entrepreneur,
Former Director Oral Maxillofacial Surgery University of Chicago Hospital
Jim
McAvoy
(Business Development Lead)
35+ years of sales and lead-generation experience
Reed
McCalmon
(CFO)
10+ years Experience in Biotech Finance
James G.
Wetrich
(Board Advisor)
Reapplix Former President
Sean
McKibben
(Board Advisor)
Head of Doctors Relations,
Former Hospital President
Meet the Team
NovaXS is led by a professional team in healthcare
with a proven track record of over 40 million fundraising experience and 5 successful business exits.
Alina
Su
(CEO & Founder)
HMS PhD Researcher, Medical Device Inventor
Jonathan
(COO & Co-Founder)
Booth MBA, Serial Entrepreneur
Martin
Ebro, PhD
(Head Advisor)
Senior Innovation Lead at Novo Nordisk
Rachel
Rubin
(Board Advisor)
Former Principal and Vice President at Roivant Health
David
Harrell
(Board Advisor)
OptimizeRX - NASDAQ: OPRX Former CEO
Fred
Zussa
(Board Advisor)
Chief Business Officer,
MIT MBA & Telecom Paris Tech Engineer
Alex
Zou
(CTO & Co-founder)
UC Berkeley Electro- engineering PhD
Irina
Conboy PhD
(Board Advisor)
UC Berkeley Bioengineering Professor
